Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CV09070101
- Development stage
- Unknown
- Lead developer
- CureVac
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, mRNA Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Parenteral, Injection
01
Overview
CV09070101 is an investigational mRNA-based cancer vaccine developed for the treatment of squamous non-small cell lung cancer (sqNSCLC). It is designed as a personalized immunotherapy to stimulate the immune system to recognize and target cancer-specific antigens. The vaccine is under development by CureVac and myNEO and acts as an immunostimulant, falling under the categories of antineoplastics, cancer vaccines, immunotherapies, and RNA vaccines. Development is in preclinical and very early clinical phases, with studies evaluating its safety and efficacy in combination with pembrolizumab and chemotherapy in advanced, inoperable, or metastatic sqNSCLC[1][3][5][9].
- Other names
- CV09070101 mRNA vaccineCV-09070101 mRNA vaccineCV 09070101 mRNA vaccine
Beyond the preview
Go deeper on CV09070101.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CV09070101.